Finding paves way for new personalized treatments to target inflammation
April 5th, 2011 - 5:29 pm ICT by ANIWashington, April 05 (ANI): Researchers have found a way of mimicking the body’s natural mechanism of fighting inflammation.
During inflammation cells release very small particles termed ‘microparticles’ that retain features of their parent cell.
Scientists at Barts and The London School of Medicine and Dentistry and Harvard Medical School, Boston discovered that certain microparticles were beneficial to health, and that these microparticles contained anti-inflammatory lipids, which help terminate inflammation and return the body to its normal balance.
The discovery paves the way for new personalized treatments to target uncontrolled inflammation that need not rely on synthetic biomaterials, therefore reducing potential toxicity.
Inflammation of joints and muscles is implicated in many human diseases including cardiovascular disease, arthritis and temporomandibular disorders and its treatment remains an unmet medical need.
Led by Dr Lucy V Norling (a Foundation Fellow of the Arthritis Research UK), researchers from the William Harvey Research Institute at Barts and The London School of Medicine and Dentistry and Harvard Medical School (laboratory of Professor CN Serhan) investigated the properties of microparticles during inflammatory episodes showing them to contain beneficial lipids (fat molecules) that are precursors for compounds that stimulate the resolution of an inflammatory episode. The researchers then mimicked this natural communication process to make a new personalized delivery system for anti-inflammatory therapeutics based on natural human microparticles instead of synthetic biomaterials, which bring adverse immunotoxic effects.
The many benefits of these humanized particles, coined ‘nano-proresolving medicines’ are that they can be loaded with anti-inflammatories (e.g. resolvins or other small molecules) to enhance their protective bioactions.
“These results uncover a novel way of targeting anti-inflammatories therapeutics to the site of inflammation using a natural delivery system. I think this new mode of delivery could have application for numerous inflammatory diseases including those of the joint such as arthritis and temporomandibular disorders,” said Norling.
The study has been featured online in the Journal of Immunology. (ANI)
- Turmeric 'the right spice' to fight colon cancer - Mar 03, 2011
- Tumeric derivative found promising in tendinitis - Aug 11, 2011
- Experimental non-steroidal treatment of asthma holds promise - Jul 02, 2010
- Turmeric can fight colon cancer - Mar 03, 2011
- Tart cherries may reduce inflammation, risk factors for heart disease - Apr 13, 2011
- New signaling pathway linked to inflammatory disease discovered - Dec 15, 2010
- Bee sting can help treat arthritis - Jun 28, 2010
- Antioxidant enzyme-containing particles may help repair injured heart - Nov 16, 2009
- Ion channel responsible for pain discovered - Dec 18, 2010
- 'Master switch' for key immune cells in inflammatory diseases found - Jan 17, 2011
- Frankincense could be an answer to treating painful joints - Jun 22, 2011
- Ginkgo Biloba extracts could treat pain, inflammation - Apr 28, 2011
- New synthetic compound shows promise in fighting HIV - Jan 19, 2011
- Nanoparticles could offer relief from skin allergies - Apr 04, 2011
- Prozac, Celexa show promise for rheumatoid arthritis treatment - Feb 25, 2010
Tags: arthritis research, barts and the london, foundation fellow, harvard medical school, harvard medical school boston, harvey research institute, human diseases, inflammation of joints, microparticles, natural communication, natural mechanism, school laboratory, school of medicine and dentistry, synthetic biomaterials, temporomandibular disorders, uk researchers, unmet medical need, william harvey, william harvey research, william harvey research institute